Skip to Content

Biomaxima SA BMX

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BMX is trading at a 38% discount.
Price
PLN 15.66
Fair Value
PLN 49.92
Uncertainty
Very High
1-Star Price
PLN 68.74
5-Star Price
PLN 26.36
Economic Moat
Gjgz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BMX is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.34
Dividend Yield (Trailing)
3.18%
Dividend Yield (Forward)
3.18%
Total Yield
3.30%

Company Profile

Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
115

Valuation

Metric
BMX
Price/Earnings (Normalized)
Price/Book Value
1.17
Price/Sales
1.34
Price/Cash Flow
31.18
Price/Earnings
BMX

Financial Strength

Metric
BMX
Quick Ratio
0.85
Current Ratio
2.24
Interest Coverage
2.81
Quick Ratio
BMX

Profitability

Metric
BMX
Return on Assets (Normalized)
< 0.01%
Return on Equity (Normalized)
< 0.01%
Return on Invested Capital (Normalized)
1.23%
Return on Assets
BMX
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncXcqbrdxhhVcxv$208.9 Bil
DHR
Danaher CorpPmjysfyqcYgtkt$177.3 Bil
IQV
IQVIA Holdings IncJddjmljGyyjrq$41.4 Bil
IDXX
IDEXX Laboratories IncWctqhmvkmDbkwys$39.7 Bil
A
Agilent Technologies IncXvcfxfvggSwh$39.4 Bil
MTD
Mettler-Toledo International IncZyccvtwnvvGyrkvpv$25.6 Bil
ICLR
Icon PLCCwbcddwtTkdglp$24.1 Bil
ILMN
Illumina IncXrkclrvFpnrlb$18.8 Bil
WAT
Waters CorpVslcdxtwlGccp$18.0 Bil
LH
Laboratory Corp of America HoldingsLwkqlmjhwGcsllpc$16.8 Bil

Sponsor Center